IP Library Granted Patent US 6,936,699
Granted Patent B2
US 6,936,699 · App. 10/275,797 · Granted Aug 30, 2005

Purification of protein inclusion bodies by crossflow microfiltration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,936,699
App. No.
10/275,797
Granted
Aug 30, 2005
Kind
B2
Abstract

The invention relates to a process for purifying and/or concentrating inclusion bodies (refractile bodies) in a highly concentrated particle-containing solution, in which process the inclusion body-containing suspension is directed tangentially past one or more semipermeable membranes, so that the inclusion bodies are retained behind the membranes and that substances having a relatively small molecular weight may pass through the membrane and/or be adsorbed to the membrane, and a purified and/or concentrated inclusion body suspension is obtained. In the same manner, cell wall particles are removed from a inclusion body suspension. The invention further relates to the use of a crossflow microfiltration unit for purifying and/or concentrating inclusion bodies in a suspension and for removing cell wall particles from a inclusion body preparation.

Claims (3)

1. A process for purifying and/or concentrating a biomass load of inclusion bodies in a solution, which is characterized in that the inclusion body-containing solution is directed tangentially past one or more semipermeable membranes so that the membranes retain the inclusion bodies and that substances or components having a relatively small molecular weight or particle diameter can pass through, thus obtaining a purified and/or concentrated inclusion body solution, and on the semipermeable membrane a planar net matrix is located which is constructed of intersecting longitudinal and transverse filaments such that the adjacent longitudinal and transverse filaments are, in each case, at a distance from one another which is 5 to 15 times greater than their thickness which is in the range from 150 to 600 μm, said matrix having a membrane to matrix distance of about 80 μm, a matrix thickness of about 760 μm, a filament thickness of about 340-450 μm and a filament distance of about 2400 μm.

2. The process according to claim 1 , characterized in that the biomass load of the membrane is greater than 65 g of wet cell mass equivalent/m 2 .

3. The process according to claim 1 , characterized in that the biomass load of the membrane is greater than 650 g of wet cell mass equivalent/m 2 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029908/0217 →